Across TCGA pan-cancer cohorts, AJAP1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated AJAP1 data layer compared with 5 for mutation status and 1 for mass-spec protein.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher AJAP1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated AJAP1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and KIRP show a favorable association.
KIRC, UVM, and LUSC are the cancer types where AJAP1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.